Floatz logo

Iodixanol

Sarcopenic Obesity

Nemocnice AGEL Trinec-Podlesi a.s.Small moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Sarcopenic Obesity cohort.

Asset / SponsorPhaseRating
VITAMIN D
Fondazione Policlinico Universitario Campus Bio-Medico
Phase 4BB
Tirzepatide
Pennington Biomedical Research Center
Phase 4BB
Metformin
VA Office of Research and Development
Phase 3B
imm01-stem
Immunis, Inc.
Phase 2CCC
Oxytocin
Sara Espinoza
Phase 1/2CCC

Same molecule, other indications

Iodixanol is also rated in:

carotid stenosisDormant
B
Indicative ·
63 / 100
View asset →
atherosclerosisDormant
B
Indicative ·
62 / 100
View asset →
Colon CancerDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →